Mark Sonderup
Biographic Data
| ID | 7449393 |
|---|---|
| NAME | Mark Sonderup |
| GIVEN NAMES | Mark |
| FAMILY NAME | Sonderup |
| SIGNATURE | SONDERUP M |
| AFFILIATIONS | Groote Schuur Hospital |
| ORCID | 0000-0001-7128-8329 |
| VERIFIED | Yes |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2017 |
| LATEST PUBLICATION YEAR | 2025 |
| H-INDEX | 0 |
A decentralized point of service triple prevention and treatment model for hepatitis B, C and HIV in people who inject drugs in South Africa
The authors declare that they have obtained ethics approval University of Cape Town HREC R0145/2014; R793/2022 from an appropriately constituted ethics committee/institutional review board where the research entailed animal or human participation
Feasibility of implementing viral hepatitis services into a correctional service facility in Cape Town, South Africa
There was a notable viral hepatitis burden among people in this correctional centre and integration of viral hepatitis services into the existing HIV services was acceptable and feasible. Further efforts to sustain and expand access to viral hepatitis services in South African correctional centres could catalyse national viral hepatitis elimination efforts
The investment case for hepatitis B and C in South Africa
Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showing that national HBV/HCV programs could have a significant impact on these epidemics and save lives in a cost-effective, affordable manner. In this co…
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
No prominent works on this page.
Global prevalence and genotype distribution of hepatitis C virus infection in 2015
The investment case for hepatitis B and C in South Africa
Even though WHO has approved global goals for hepatitis elimination, most countries have yet to establish programs for hepatitis B and C, which account for 320 million infections and over a million deaths annually. One reason for this slow response is the paucity of robust, compelling analyses showing that national HBV/HCV programs could have a significant impact on these epidemics and save lives in a cost-effective, affordable manner. In this co…
A decentralized point of service triple prevention and treatment model for hepatitis B, C and HIV in people who inject drugs in South Africa
The authors declare that they have obtained ethics approval University of Cape Town HREC R0145/2014; R793/2022 from an appropriately constituted ethics committee/institutional review board where the research entailed animal or human participation
Feasibility of implementing viral hepatitis services into a correctional service facility in Cape Town, South Africa
There was a notable viral hepatitis burden among people in this correctional centre and integration of viral hepatitis services into the existing HIV services was acceptable and feasible. Further efforts to sustain and expand access to viral hepatitis services in South African correctional centres could catalyse national viral hepatitis elimination efforts
Hepatitis B Virus Studies (4 works) · Medicine (4 works) · Business (3 works) · Hepatitis C virus research (3 works) · Economic growth (2 works) · Environmental health (2 works) · Geography (2 works) · Hepatitis C (2 works) · Marketing (2 works) · Service (business (2 works)